Belka C - Search Results

1

Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data.

Schnöller LE, Piehlmaier D, Weber P, Brix N, Fleischmann DF, Nieto AE, Selmansberger M, Heider T, Hess J, Niyazi M, Belka C, Lauber K, Unger K, Orth M. Schnöller LE, et al. Among authors: belka c. Radiat Oncol. 2023 Mar 11;18(1):51. doi: 10.1186/s13014-023-02241-4. Radiat Oncol. 2023. PMID: 36906590 Free PMC article.

2

Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.

Rudner J, Jendrossek V, Lauber K, Daniel PT, Wesselborg S, Belka C. Rudner J, et al. Among authors: belka c. Oncogene. 2005 Jan 6;24(1):130-40. doi: 10.1038/sj.onc.1208191. Oncogene. 2005. PMID: 15531922

3

The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro.

Rübel A, Handrick R, Lindner LH, Steiger M, Eibl H, Budach W, Belka C, Jendrossek V. Rübel A, et al. Among authors: belka c. Radiat Oncol. 2006 Mar 29;1:6. doi: 10.1186/1748-717X-1-6. Radiat Oncol. 2006. PMID: 16722524 Free PMC article.

4

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

5

Counting colonies of clonogenic assays by using densitometric software.

Niyazi M, Niyazi I, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2007 Jan 9;2:4. doi: 10.1186/1748-717X-2-4. Radiat Oncol. 2007. PMID: 17212832 Free PMC article.

6

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Among authors: belka c. Strahlenther Onkol. 2009 Jan;185(1):8-18. doi: 10.1007/s00066-009-1856-4. Epub 2009 Feb 18. Strahlenther Onkol. 2009. PMID: 19224142

7

Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Among authors: belka c. Oncol Rep. 2009 Jun;21(6):1455-60. doi: 10.3892/or_00000374. Oncol Rep. 2009. PMID: 19424623

8

Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways.

Li M, Jung A, Ganswindt U, Marini P, Friedl A, Daniel PT, Lauber K, Jendrossek V, Belka C. Li M, et al. Among authors: belka c. Biochem Pharmacol. 2010 Jan 15;79(2):122-9. doi: 10.1016/j.bcp.2009.08.011. Epub 2009 Aug 15. Biochem Pharmacol. 2010. PMID: 19686703

9

Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.

Marini P, Budach W, Niyazi M, Junginger D, Stickl S, Jendrossek V, Belka C. Marini P, et al. Among authors: belka c. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):198-202. doi: 10.1016/j.ijrobp.2009.04.038. Int J Radiat Oncol Biol Phys. 2009. PMID: 19695436

10

Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.

Marini P, Junginger D, Stickl S, Budach W, Niyazi M, Belka C. Marini P, et al. Among authors: belka c. Radiat Oncol. 2009 Oct 27;4:49. doi: 10.1186/1748-717X-4-49. Radiat Oncol. 2009. PMID: 19860913 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters